ACUSENSUS LIMITED (ACE)
Share Price Analysis and Chart

Enter the company code or Name for stock analysis:

ACE

ACE - ACUSENSUS LIMITED

FNArena Sector : Transportation & Logistics
Year End: June
GICS Industry Group : Software & Services
Debt/EBITDA: -0.62
Index: ALL-ORDS

0

LAST PRICE CHANGE +/- CHANGE % VOLUME

$1.29

28 Aug
2026

0.020

OPEN

$1.21

1.57%

HIGH

$1.29

263,924

LOW

$1.21

TARGET
$1.765 36.8% upside
OTHER COMPANIES IN THE SAME SECTOR
AIZ . AQZ . AVD . AZJ . BWN . BXB . CLX . ERD . FRW . KLS . KSC . LAU . NTD . QAN . SPZ . SST . THL . VGN . WTC .
FNARENA'S MARKET CONSENSUS FORECASTS
ACE: 1
Title FY25
Actual
FY26
Actual
FY27
Forecast
FY28
Forecast
EPS (cps) xxx - 15.7 - 3.3 xxx
DPS (cps) xxx 0.0 0.0 xxx
EPS Growth xxx N/A N/A xxx
DPS Growth xxx N/A N/A xxx
PE Ratio xxx N/A N/A xxx
Dividend Yield xxx N/A 0.0% xxx
Div Pay Ratio(%) xxx N/A N/A xxx

Dividend yield today if purchased 3 years ago: 0.00%

DIVIDEND YIELD CALCULATOR

Dividend Yield Today On Last Actual Payout :

0.00

Estimated Dividend Growth
(Average Of Past Three Years)

 %

Amount Invested

Tell Me The Dividend After This Many Years

Past performance is no guarantee for the future. Investors should take into account that heavy swings in share price or exceptional circumstances (a la 2009) can have a significant impact on short term calculations and averages
HISTORICAL DATA ARE ALL IN AUD
Copyright © 2026 FactSet UK Limited. All rights reserved
Title 202120222023202420252026
EPS Basic xxxxxxxxxxxxxxx-15.7
DPS All xxxxxxxxxxxxxxx0.0
Sales/Revenue xxxxxxxxxxxxxxx86.2 M
Book Value Per Share xxxxxxxxxxxxxxx37.5
Net Operating Cash Flow xxxxxxxxxxxxxxx-3.0 M
Net Profit Margin xxxxxxxxxxxxxxx-28.19 %

EPS Basic

DPS All

Sales/Revenue

Book Value Per Share

Net Operating Cash Flow

Net Profit Margin

Title 202120222023202420252026
Return on Capital Employed xxxxxxxxxxxxxxx-44.02 %
Return on Invested Capital xxxxxxxxxxxxxxx-40.44 %
Return on Assets xxxxxxxxxxxxxxx-28.73 %
Return on Equity xxxxxxxxxxxxxxx-44.02 %
Return on Total Capital xxxxxxxxxxxxxxx-37.99 %
Free Cash Flow ex dividends xxxxxxxxxxxxxxx-19.5 M

Return on Capital Employed

Return on Invested Capital

Return on Assets

Return on Equity

Return on Total Capital

Free Cash Flow ex dividends

Title 202120222023202420252026
Short-Term Debt xxxxxxxxxxxxxxx3 M
Long Term Debt xxxxxxxxxxxxxxx5 M
Total Debt xxxxxxxxxxxxxxx8 M
Goodwill - Gross xxxxxxxxxxxxxxx-
Cash & Equivalents - Generic xxxxxxxxxxxxxxx25 M
Price To Book Value xxxxxxxxxxxxxxx3.30

Short-Term Debt

Long Term Debt

Total Debt

Goodwill - Gross

Cash & Equivalents - Generic

Price To Book Value

Title 202120222023202420252026
Capex xxxxxxxxxxxxxxx18.3 M
Capex % of Sales xxxxxxxxxxxxxxx21.20 %
Cost of Goods Sold xxxxxxxxxxxxxxx83 M
Selling, General & Admin. Exp & Other xxxxxxxxxxxxxxx27 M
Research & Development xxxxxxxxxxxxxxx-
Investments - Total xxxxxxxxxxxxxxx0 M

Capex

Capex % of Sales

Cost of Goods Sold

Selling, General & Admin. Exp & Other

Research & Development

Investments - Total

EXPERT VIEWS
Display All Commentary

Sentiment Indicator

1.0

No. Of Recommendations

2
BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Morgans

xx/xx/xxxx

1

xxxxxxxxxxx xxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Ord Minnett

26/08/2026

1

Buy

$1.53

18.60%

Ord Minnett retains Buy on Acusensus and raises its target by 3% to $1.53 following a "solid" FY26 result.

Revenue rose 45% to $86m, while adjusted earnings (EBITDA) increased 49% to $8.5m and exceeded guidance.

International growth accelerated sharply, while all Australian contracts due for renewal were retained and 75% expanded.

Commentary suggests FY27 revenue guidance of $100m-$106m appears achievable, with $97m already contracted.

Ord Minnett believes guidance may prove conservative and sees Acusensus retaining technical and first-mover advantages supporting domestic and international growth.

EXTRA COVERAGE
Display All Commentary

No. Of Recommendations

1

Please note: unlike Broker Call Report, BC Extra is not updated daily. The info you see might not be the latest. FNArena does its best to update ASAP.

BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Canaccord Genuity

09/03/2026

1

Buy

$2.50

93.80%

Acusensus delivered a first half result that was in line with estimates and reiterated FY26 guidance for revenue to increase 40-46% to $83-87m.

The company is investing, increasing its "innovation activities" to $4m with operating and capital expenditure stepping up to -$22m, announcing the expansion of its multifunction fixed enforcement contract in Western Australia with incremental value of $11m to the original contract worth $9m.

Canaccord Genuity asserts the business has a bespoke, proprietary and industry-specific AI model that should provide significant protection against potential competitor-driven disruption. Buy rating unchanged. Target rises to $2.50 from $2.30.

FORECAST
Canaccord Genuity forecasts a full year FY27 dividend of 0.00 cents.

ACE STOCK CHART